Oncotelic Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
Oncotelic Therapeutics, Inc. (OTLC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -1.40% for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-10.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2019-04-10
- Oncotelic Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2018 was -1.40%.
- Oncotelic Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2017 was -0.50%.
- Oncotelic Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2016 was -0.40%.
- Oncotelic Therapeutics, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2015 was -0.11%, a 320.00% decline from fiscal 2014.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2018-12-31 | -1.40% 10-K · filed 2019-04-10 | |
| 2017-12-31 | -0.50% 10-K · filed 2019-04-10 | |
| 2016-12-31 | -0.40% 10-K · filed 2018-04-17 | -0.37% 10-K · filed 2017-03-30 |
| 2015-12-31 | -0.11% 10-K · filed 2017-03-30 | 0.11% 10-K · filed 2016-03-25 |
| 2014-12-31 | 0.05% 10-K · filed 2016-03-25 | -0.05% 10-K · filed 2015-03-30 |
| 2013-12-31 | -0.31% 10-K · filed 2015-03-30 | |
| 2012-12-31 | -0.54% 10-K · filed 2014-03-20 | |
| 2011-12-31 | -4.31% 10-K · filed 2013-03-15 |